Foam cells promote atherosclerosis progression by releasing CXCL12 | Zendy

Lingxing Li | Zendy; Zhenlan Du | Zendy; Bing Rong | Zendy; Dapeng Zhao | Zendy; Aiping Wang | Zendy; Yuzhen Xu | Zendy; Huanyi Zhang | Zendy; Xue Bai | Zendy; Jingquan Zhong | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Foam cells promote atherosclerosis progression by releasing CXCL12

Author(s) -

Lingxing Li,

Zhenlan Du,

Bing Rong,

Dapeng Zhao,

Aiping Wang,

Yuzhen Xu,

Huanyi Zhang,

Xue Bai,

Jingquan Zhong

Publication year - 2020

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20193267

Subject(s) - oil red o , vascular smooth muscle , chemokine , staining , in vitro , in vivo , cell growth , h&e stain , inflammation , mtt assay , cell , immunohistochemistry , chemistry , ex vivo , microbiology and biotechnology , biology , medicine , pathology , immunology , endocrinology , biochemistry , smooth muscle , adipogenesis

Atherosclerosis (AS) is a chronic inflammatory disease that contributes to multiple cardiovascular diseases (CVDs), and foam cell formation plays important roles in the progression of AS. There is an urgent need to identify new molecular targets for treating AS, and thereby improve the quality of life and reduce the financial burden of individuals with CVD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research